IL6 and bronchopulmonary dysplasia: Prior work has predominantly focused on neonatal inflammatory biomarkers—such as C-reactive protein, IL-6, or early postnatal NLR—as predictors of BPD risk (16, 17), whereas maternal hematologic indices have received far less attention.